Literature DB >> 33871066

Clinical application of heparin in the treatment of severe acute pancreatitis - A new discovery of the HMGB1 pathway.

Xianqiang Yu1, Weiqin Li1.   

Abstract

Entities:  

Keywords:  HMGB1; heparin; inflammation; sepsis; severe acute pancreatitis

Mesh：

Substances：

Year:  2021        PMID： 33871066      PMCID： PMC8358710          DOI： 10.1111/imm.13342

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.215


× No keyword cloud information.
  2 in total

1.  Heparin prevents caspase-11-dependent septic lethality independent of anticoagulant properties.

Authors:  Yiting Tang; Xiangyu Wang; Zhaozheng Li; Zhihui He; Xinyu Yang; Xiaoye Cheng; Yue Peng; Qianqian Xue; Yang Bai; Rui Zhang; Kai Zhao; Fang Liang; Xianzhong Xiao; Ulf Andersson; Haichao Wang; Timothy R Billiar; Ben Lu
Journal:  Immunity       Date:  2021-02-08       Impact factor: 31.745

2.  LincRNA-EPS alleviates severe acute pancreatitis by suppressing HMGB1-triggered inflammation in pancreatic macrophages.

Authors:  Shengchuan Chen; Jingfei Zhu; Li-Qiong Sun; Siying Liu; Tan Zhang; Yuepeng Jin; Chaohao Huang; Dapei Li; Haiping Yao; Jian Huang; Yanghua Qin; Mengtao Zhou; Gang Chen; Qiyu Zhang; Feng Ma
Journal:  Immunology       Date:  2021-03-07       Impact factor: 7.215
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.